Trimethoprim-sulfamethoxazole-induced tremor in an immunocompetent patients.
Trimethoprim-sulfamethoxazole (TMP-SMX) is a widely administered antibiotic that is well tolerated by most patients. Hypersensitivity reactions and gastrointestinal intolerance are the most common adverse events associated with it. Central nervous system adverse effects such as tremors are less common and occur primarily in patients with acquired immune deficiency syndrome. A 29-year-old immunocompetent man developed a tremor while taking TMP-SMX. The tremor resolved within 2 days after the drug was discontinued.
Patterson
R G
RG
Saint Louis University Belleville Family Practice, Missouri, USA.
Couchenour
R L
RL
D000328:Adult; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004756:Enterobacteriaceae Infections / Q000188:drug therapy; D006801:Humans; D007121:Immunocompetence; D008297:Male; D011183:Postoperative Complications / Q000188:drug therapy; D014202:Tremor / Q000139:chemically induced*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage / Q000009:adverse effects*
D000890:Anti-Infective Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination